Could Germany’s Proposed Drug Pricing Reform Impact United States?
The German committee responsible for assessing drug efficacy and setting prices may cut the initial 12-month review time by 50%. [...]
Researchers Claim Drug Price Limits Won’t Impact Innovation, PhRMA Strongly Disagrees
In a recently published article, researchers at Bentley University and West Health conclude that limiting drug prices will not affect [...]
Should the FDA Follow Advisory Committee Votes in Drug Approvals?
A recent survey requested feedback from advisory committee members. Most respondents thought that a thumbs down from committee members should [...]
Vanderbilt Scientist and Aetion RWE Strategist Highlight Seven Solutions to Bolster FDA’s Accelerated Approval Process and Achieve Value-Based Pricing
Aetion’s Dr. Nirosha Mahendraratnam Lederer and Vanderbilt’s Dr. Stacie B. Dusetzina discuss how value-based pricing may be achieved using the [...]
Refocus PMPRB “Back to the Future”: Prevent Excessive Drug Pricing
August 19, 2021 from 1-2 pm CORD’s LAST SUMMER webinar, Part 1 of our series on “How to Get Back [...]
Lessons from the Field – Ugc – the Holy Grail of Thought Leadership for Healthcare Vendors
User Generated Content (UGC) is the holy grail for healthcare vendors when all is said and done. It doesn’t matter [...]
Managing cybersecurity for healthcare providers is complicated. But there is a cure.
As a customer success manager, I had the pleasure of working with Frederick Health, a leading healthcare provider in Frederick [...]
Exclusive Interaction: Role Of Big Data And AI In Digital Transformation Of Healthcare And Lifesciences Industry
Satish Pala, CTO-Indium Software - How do Big Data and AI help hospitals handle complaints better? Being a fast-paced sector, [...]
Google Health’s David Feinberg Joins Cerner as CEO
Health information company Cerner has announced that Dr. David Feinberg will lead the company as Chief Executive Officer. “Dr. David [...]
After Aduhelm fallout, FDA veteran Woodcock out of running for commish job: report
After Aduhelm fallout, FDA veteran Woodcock out of running for commish job: report badams Fri, 08/20/2021 - 08:32 Read the [...]
Inovalon to Be Acquired by Equity Consortium Led by Nordic Capital Including Insight Partners for $7.3 BillionStockholders to Receive $41.00 Per Share in Cash
Inovalon to Be Acquired by Equity Consortium Led by Nordic Capital Including Insight Partners for $7.3 BillionStockholders to Receive $41.00 [...]
Healthcare & Life Sciences: Drug Pricing Digest – August 2021 #2
$1 Trillion Infrastructure Bill Includes Two Drug Pricing Provisions: On Aug. 10, 2021, the Senate passed H.R. 3684, the Investing [...]
Podcast #151 New Data Revolution
Conversation with Milind Chitgupakar Milind is the world-recognized expert in designing, developing, and operationalizing some of the largest data platforms, [...]
GoodRx reports spike in drug discount subscribers driving 43% revenue growth in Q2
More consumers using its app to buy prescription drugs at lower prices and an uptick in subscribers helped boost GoodRx's [...]
UK’s NICE to revamp its processes to make access to medicines “fairer”
The launch of the National Institute for Health and Care Excellence (NICE) in 1999 was surrounded in controversy, primarily because [...]
Health & Medical Economics Journals | open access journals
Health is considered as the major wealth of our life. Present day’s system claims huge medical expenditure for individuals as [...]
Legacies: 60 biopharma pioneers over 60 who helped birth a tech revolution in the making
Over the last couple of months, we’ve lost two of the most prominent people in biopharma. José Baselga and John [...]
The Endpoints 100 survey: CEOs changed the way biotechs operate during the pandemic. Things will never be the same …
With the US at the front of the line for new Covid-19 vaccines, the biotech industry is looking at the [...]
The CHIC interview: Stéphane Bancel on Moderna’s overnight transformation, the new timeline on vaccine development …
The China Healthcare Investment Conference — better known as CHIC — took place last week in Shanghai at the Ritz-Carlton [...]
The 20(+1) under 40: Inside the next generation of biotech leaders
How does one decide who makes an “under 40” list? After the last nominations come in from staff and readers, [...]
BMS buys into AI-designed immune drug from Exscientia
Bristol Myers Squibb has exercised an option on an immune-modulating drug candidate developed by UK artificial intelligence specialist Exscientia, paying [...]
Alex Gorsky will pass leadership of J&J to Joaquin Duato in January
Johnson & Johnson has appointed Joaquin Duato as chief executive officer to replace long-serving Alex Gorsky, who has been CEO [...]
How to improve payer engagement with tailored value communication
Pharmaceutical drug success rests on being able to achieve market access. Brands are facing increasing pressure to demonstrate strong value [...]
Using AI to make a big impact for emerging and mid-sized biopharma companies
With recent market changes catalysing a rapid shift to an omnichannel approach, life science organisations of every size are racing [...]
Does draft RCT guide set the scene for future trials?
A common set of standards for randomised clinical trials (RCTs) aims to help researchers develop the drugs and interventions of [...]